Cefotaxime (CTX) and HRE664 (a novel penem antibiotic) possess complementary in vitro properties. Differences can be observed in their antibacterial spectra, their /3-lactamase stability and -inhibition, and their affinity to penicillin-binding proteins. These differences suggested that combinations of the cephalosporin and the penem antibiotic would be advantageous and should be studied. The fractional inhibitory concentration values of checkerboard studies confirmed that CTXand HRE664 act synergistically against various Gram-positive and Gram-negative bacteria. These bacteria usually produce CTXdestroying^-lactamases. The highest numbers of CTX-resistant strains are found among Pseudomonas aeruginosa, Enterobacter cloacae and Bacteroides fragilis. Considerable numbers of Enterococcal strains are also resistant to CTX. Furthermore, the MICof CTXfor Staphylococci -especially methicillin-resistant strains -are far higher than for most Enterobacteriaceae1"^. HRE664 (E 83 1664) is a penem antibiotic with a broad spectrum including Gram-positive and Gram-negative aerobic and anaerobic bacteria. The in vitro activity of HRE664 against Grampositive bacteria especially Staphylococci (including methicillin-resistant strains) is higher than that of CTX. CTX-sensitive Gram-negative bacteria are also sensitive to HRE664. However HRE664 is muchmore active against the CTX-resistant,^-lactamase producing strains of Enterobacter sp. and B. fragilis*'^.
The high antibacterial potency of HRE664 depends on its high stability towards plasmid-coded and chromosomally-coded /3-lactamases4'5). In vitro studies showed that HRE 664 is not only /3-lactamase stable but is also an efficient inhibitor of these enzymes4>5). HRE664 binds to PBPs 2, 5 and 6 of Escherichia coli*>l). The complementary in vitro properties of CTX and HRE 664 gave rise to investigations on their combined activity in vitro.
Conventional "checkerboard" studies were performed using a number of strains. To obtain more information we also tested the activity of a fixed combination of CTXand HRE664 against a great number of different bacteria. The MICsof the test compoundfor anaerobic bacteria were read after 48 hours at 37°C in anaerobic jars (Oxoid) and those for aerobes after 24 hours at 37°C. The MICwas taken as the lowest concentration of the test substance, at which no visible growth could be detected in the area of the inoculation spot after the incubation time. A haze of growth or a single colony was disregarded in the reading.
"Checkerboard" Combination Studies
The combined activity of CTXand HRE664 was measured using the checkerboard method in conjunction with the agar-dilution test. MHagar (Difco) was used as the test medium. Stationary cultures of the test strains served as inocula after dilution by 1 :10. After 18 hours at 37°C the MICswere read both from the controls containing only one of the antibiotics and from the plates containing the combination. The "fractional inhibitory concentrations (FICs)"6) were calculated from these values using the 
Res ults
Checkerboard Studies Table 1 shows the MICs of CTXand HRE 664 alone and the FIC values of their combinations against various Gram-negative and Grampositive bacteria. In 17 out of 20 strains tested, FIC values of <0.5 were obtained and indicate synergism between CTX and HRE 664. The synergism is shown graphically in Fig. 1 for two strains of E. cloacae. Thus Staphylococci (including methicillin-resistant strains) ( Table 2 ) and Enterobacter sp. (Table Table 3 . In vitro activity of cefotaxime (CTX), HRE664-mixtures against aerobic Gram-negative bacteria.
MIC Og/ml) 4) are included in the antibacterial spectra of the combinations. P. aeruginosa (Table 3 ) was the only species against which positive combination effects were not observed. One of the major gaps in the antibacterial spectrum of CTXis the limited activity against Gramnegative anaerobes, especially B. fragilis. /3-Lactamase producers among these strains are resistant to CTXand many of the non-producers are only moderately sensitive. Table 5 shows the results of our studies with fixed combinations of CTXand HRE664 against obligate anaerobic bacteria. The addition of only 20 % ofHRE 664 to CTXmakes the resulting combination as active as HRE664 alone.
That means that Gram-negative anaerobes (B. fragilis, Bacteroides thetaiotaomicrori) are fully sensitive to the HRE664/CTX-combinations independent of their ability to produce /3-lactamase. HRE664 is a new penemantibiotic with a very broad antibacterial spectrum. It includes -with the exception of P. aeruginosa -nearly all Gram-positive and Gram-negativeanaerobes and aerobes tested. The MICs of HRE664 against some bacteria are slightly higher than those of CTX, but in certain cases it is markedly lower {e.g. Staphylococci-including methicillin-resistant strains, Enterobacter sp., B. fragilis).
The /3-lactamase stability of HRE664 and especially its^-lactamase inhibitory potency is higher than that of CTX45). HRE664 binds preferentially to the PBPs 2, 3c, 5 and 6, whereas CTX show high affinity to PBPs la, lb and 34»5).
The important properties of both HRE664 and CTXare obviously complementary. This hypothesis was confirmed by the in vitro studies on the combined activity of both compounds. We investigated the in vitro activity of the combination of HRE664 and CTX. Checkerboard studies revealed synergistic activity of both antibiotics against nearly all strains tested. Fixed mixtures of CTXand HRE664 possess high antibacterial activity and broad antibacterial spectra, excluding Pseudomonas, but clearly including Staphylococci, Enterobacter sp. and B. fragilis. The mixtures combine the advantages of both single compoundsCTXand HRE664.
